Impact of the Cancer Risk Intake System on Patient‐Clinician Discussions of Tamoxifen, Genetic Counseling, and Colonoscopy
Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA. Impact of the Cancer Risk Intake System on Patient‐Clinician Discussions of Tamoxifen, Genetic Counseling, and Colonoscopy. Journal Of General Internal Medicine 2005, 20: 360-365. PMID: 15857495, PMCID: PMC1490091, DOI: 10.1111/j.1525-1497.2005.40115.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAlgorithmsAntineoplastic Agents, HormonalBreast NeoplasmsColonic NeoplasmsColonoscopyCommunicationCounselingFemaleGenetic CounselingHumansMaleMiddle AgedOdds RatioOvarian NeoplasmsPatient Acceptance of Health CarePatient Education as TopicPhysician-Patient RelationsPrimary Health CareRisk AssessmentTamoxifenConceptsPatient-clinician discussionsPrimary care settingCare settingsGenetic counselingBaseline telephone surveyObjective cancer riskMonths postvisitClinic visitsCancer riskTelephone surveyColonoscopySurvey 1TamoxifenPretest-posttest designGreater proportionComputerized programCounselingManagement recommendationsRisk management recommendationsParticipantsPostvisitFollowProportionSettingBaseline